THERAPIES IN CANCER TREATMENT: AN OVERVIEW
Keywords:
Cryotherapy, Gene therapy, Laser therapy, Proton therapy, Thermo therapyAbstract
Cancer is one of the most frequent and distressing diseases. The mortality caused by cancer and its prevalence has increased during the last 50 years. Cancer is still one of the most destructive disease of human beings due to its complexity and progressive nature and the clinical management of this deadly disease continue to be a challenge for the 21stcentury. Various types of cancer are reported in literature such as Carcinoma, Sarcoma, Lymphoma, leukemia, Blastoma and Germ cell tumor. There is a continuous need for new and better cancer therapies. A few years ago, surgery and radiotherapy were the only effective way to fight tumor growth. Now various therapies for the treatment of cancer have been developed including chemotherapy, radiation therapy, proton therapy, thermotherapy, Photodynamic therapy, laser therapy, sentinel lymph node biopsy, cryotherapy and differentiation therapy. These therapies have dramatically changed the scenario of cancer treatment. Further research is also needed to discriminate the various genes and signaling pathways in the process of the carcinogenesis of cancer stem cells for the development of novel therapies, with the ultimate goal of eliminating the residual disease and recurrence. This review aims to present the various types, stages of cancer and also focus on various therapies used for the treatment of cancer.
Â
Downloads
References
Global cancer rates could increase by 50% to 15 million by 2020. World Health Organization. Available from: http: //www. who. int/mediacentre/news/releases/2003/pr27/en.[Last Accessed: March 13, 2014].
Global cancer facts and figures. American cancer society. Available from: http: //www. cancer. org/acs/groups/content/@epidemiologysurveilance. [Last Accessed March 15, 2014].
Kairemo K, Erba P, Bergstrom K, Pauwels EKJ. Nanoparticles in Cancer. Curr Radiopharm 2008;1:30-6.
Seufferlein T, Ahn J, Krndija D, Lother U, Adler G, Wichert GV. Tumor biology and cancer therapy: an evolving relationship. Cell Commun Signaling 2009;7(19):1-10.
Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Del Rev 2004;56:1649-59.
Seyfried TN, Shelton LM. Cancer as a metabolic disease. Nutr Metab 2010;7:1-22.
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57–70.
Bernstein L, Gurney JG. Carcinomas and other malignant epithelial neoplasms. Available from: http: //seer. cancer. gov/publications/childhood/carcinomas. pdf. [Accessed March 25, 2014].
Banerjee AK. Preinvasive lesions of the bronchus. J Thorac Oncol 2009;4:545-51.
Shulstad RM, Proper S. Squamous cell carcinoma: a review of etiology, Pathogenesis, Treatment, and Variants. J Dermatol Nurses' Assoc 2010;2:12-6.
Eldridge L. Large cell carcinoma of the lungs: symptoms, treatments, and prognosis. Available from: http: //lungcancer. about. com/od/typesoflungcance1/a/large-cell-carcinoma-of-the-lungs. html. [Accessed: April 5, 2014].
Renner G. Small cell carcinoma of the head and neck: a review. Semin Oncol 2007;34:3-14.
Walker RI, Suvarna K, Mathews S. Pulmonary blastoma: presentation of two atypical cases and review of the literature. Br J Radiol 2005;78:437-40.
Machet MC, Muret AD, Brie J, Goga D, Grangeponte MC. Histological classification of sarcomas. Rev Stomatol Chir Maxillofac 1995;96:142-7.
Advanced Alternative Sarcoma Treatment. Available from: http: //www. sunridgemedical. com/sarco ma. [Accessed: April 8, 2014].
Longhi A, Errani C, Paolis MD, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006;32(6):423-36.
Lymphoma: A detailed description. Available from: http: //www. lymphomation. org/about-details. htm. [Accessed April 10, 2014].
Zachary HW, Matthew JM. Advances in the diagnosis and management of lymphoma. Blood Lymphatic Cancer Targets Ther 2012;2;29–55.
Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009;9:15-27.
Connors MJ. Clinical manifestations and natural history of Hodgkin’s Lymphoma. Cancer J 2009;15(2):124-8.
Mounier N, Spina M, Spano PJ. Hodgkin Lymphoma in HIV positive Patients. Curr HIV Res 2010;8(2):141-6.
Carbone A, Gloghini A, Serraino D, Spina M. Hodgkin’s disease in patient with HIV infection. Adv Haematol 2011;4(1):3-10.
Gloghini A, Carbone A. Why would the incidence of HIV-associated Hodgkin lymphoma increase in the setting of improved immunity. Int J Cancer 2007;120(12):2753-54.
Banarjee D. Recent advances in the pathobiology of Hodgkin's lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies. Adv Haematol 2011;99(12):811-26.
Nowak D, Stewart D, Koeffler PH. Differentiation therapy of leukemia: 3 decades of development. Blood 2009;113(16):3655-65.
Acosta DE, Pelayo R. Lineage switching in acute leukaemias: a consequence of stem cell plasticity. Bone Marrow Res 2012;2012:1-18.
Teitell MA, Pandolfi PP. Molecular Genetics of acute Lymphoblastic leukemia. Annu Rev Pathol 2009;4:175-98.
Hodgson K, Ferrer G, Montserrat E, Moreno C. Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematol 2011;96(5):752-61.
Lowenberg B, Downing R, Burnett J. Acute myeloid leukemia. N Engl J Med 1999;341:1051-62.
Colvin GA, Elfenbein GJ. The latest treatment advances for acute myelogenous leukemia. Med Health RI 2003;86(8):243–46.
Estey E, Dohner H. Acute myeloid leukemia. Lancet 2006;368(9550):1894-907.
Ravella S, Padmanabhan S, Curiel T, Giles F. Current status of therapy for chronic myeloid leukemia: a review of drug development. Future Oncol 2008;4(3):359-77.
Golomb MH. Hairy cell leukemia: treatment successes the past 25 years. J Clin Oncol 2008;26(16):2607-09.
Wanko OS, Castro C. Hairy cell leukemia: an elusive but treatable disease. Oncologist 2006;11(7):780-9.
Alwadani F. T-cell prolymphocytic leukemia presenting as red eye. Middle East Fr J Ophthalmol 2011;18(1):77–9.
Rosea GM, Berlinerb M. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 2004;9(3):247-58.
Naseem S, Gupta R, Kashyap R, Nityanand S. T-cell Prolymphocytic leukemia: a report of two cases with review of Literature. Indian J Hematol Blood Transfus 2008;24(4):178–81.
Bareau B, Rey J, Hamidou M, Donadieu J, Morcet J, Reman O, et al. Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases. Haematol 2010;95(9):1534–41.
Lwanga M, Watanabe T, Yamagucghi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbio 2012;322(3):1-13.
Oosterhuis WJ, Looijenga JHL. Testicular germ-cell tumors in a broader perspective. Nat Rev Cancer 2005;5:210-22.
Cools M, Drop SLS, Wolffenbuttel PK, Looijenga JHL, Oosterhuis WJ. Germ cell tumors in the Intersex Gonad: Old Paths, New Directions, Moving Frontiers. Endocr Rev 2006;277(5):468-84.
Ulbright TM. Germ cell tumors of the gonads: review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005;18(2):61–79.
Lensch MW, Ince TA. The terminology of teratocarcinomas and teratomas. Nat Biotechnol 2007;25(11):1211-2.
Cancer staging. National cancer institute fact sheet. Available from: http: //www. cancer. gov/cancer topics/Factsheet/detection/staging. [Accessed May 03, 2014].
Urruticoechea A, Alemany R, Balart J, Villanueva A, Vinals F, Capella G. Recent advances in cancer therapy: an overview. Curr Pharm Des 2010;16:3-10.
Aggarwal S. Targeted cancer therapies. Nat Rev Drug Discovery 2010;9:427-8.
Higgins MJ, Baselga J. Targeted therapies for breast cancer. J Clin Invest 2011;121:3797–803.
Williams GH, Stoeber K. The cell cycle and cancer. J Pathol 2012;226:352-64.
Vincent T, Vita D, Edward C. A history of cancer chemotherapy. Cancer Res 2008;68(21):8643–53.
Hassan MS, Ansari J, Spooner D, Hussain SA. Chemotherapy for breast cancer (Review). Oncol Rep 2010;24:1121-31.
Meyers AC. How chemotherapy damage the central nervous system. J Biol 2008;7(11):1-3.
Ismaili N, Amzerin M, Flechon A. Chemotherapy in advanced bladder cancer: current status and future. J Hematol Oncol 2011;4(35):1-12.
Fardell JE, Vardy J, Johnston IN, Winocur G. Chemotherapy and cognitive impairment: treatment options. Clin Pharmacol Ther 2011;90(3):366–76.
Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 2012;366(7):601-9.
Hung FC, Yang CY, Wang C, Chang LC, Lai ZY, Wu CC. Dose-dense chemotherapy improves the mechanisms of antitumor immune response. Cancer Res 2013;73(1):119-27.
Understanding radiation therapy: a guide for patients and families. American cancer society. Available from: http: //www. cancer. org/acs/groups/cid/documents/webcontent/003028. [Accessed May 18, 2014].
Murphy JO, Sacchini VS. New innovative techniques in radiotherapy for breast cancer. Minerva Chir 2013;68(2):139-54.
Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012;9:193-9.
Radiation therapy for cancer. National cancer institute fact sheet. Available from: http: //www. cancer. gov/cancertopics/factsheet/therapy/radiation. [Accessed June 05, 2014].
Nutting C, Webb F, Dearnaley PD. Intensity modulated radiation therapy: a clinical review. Brit J Radiol 2000;73:459-69.
Bonnett ED. Current developments in proton therapy: a review. Phys Med Biol 1993;38(10):1371-92.
Kayser-Hill EC, Both S, Tochner Z. Proton therapy: ever shifting sands and the opportunities and obligations within. Front Oncol 2011;1(24):1-9.
Proton therapy for cancer: a new technology brief. NCI cancer Bulletin. Available from: http: //www. cancer. gov/ aboutnci/ncicancerbulletin/archive/2009/090809/page8. [Accessed June 25, 2014].
Olsen RD, Bruland SO, Frykholm G, Norderhaug NI. Proton therapy–A systematic review of clinical effectiveness. Radiother Oncol 2007;83(2):123-32.
Glazer SE, Curley AS. The ongoing history of thermal therapy for cancer. Surg Oncol Clin N Am 2011;20:229–35.
Van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002;13:1173–84.
Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol/Hematol 2002;43:33–56.
Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3:487–97.
Soares PI, Ferreira IM, Igreja RA, Novo CM, Borges JP. Application of hyperthermia for cancer treatment: recent patent review. Recent Pat Anticancer Drug Discov 2012;7:64-73.
Chang E, Alexander HR, Libutti SK, Hurst R, Zhai S, Figg WD, et al. Laparoscopic continuous hyperthermic peritoneal perfusion. J Am College of Surgeons 2001;193(2):225–9.
Hyperthermia in cancer treatment. National cancer institute. Available from: http: //www. cancer. gov/cancertopics/factsheet/Therapy/hyperthermia. [Accessed: July12, 2014].
Triesscheijn M, Baas P, Schellens JH, Stewart FA. Photodynamic therapy in oncology. Oncologist 2006;11(9):1034-44.
Aniello DR, Daniele N, Aldo DL. Advances in photodynamic therapy of cancer. Curr Cancer Ther Rev 2011;7:234-47.
Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3(5):380–7.
Juarranz A, Jaen P, RodrÃguez FS, Cuevas J, Gonzalez S. Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 2008;10:148-54.
Simone CB, Friedberg JS, Glatstein E, Stevenson JP, Sterman DH, Hahn SM, et al. Photodynamic therapy for the treatment of non-small cell lung cancer. J Thorac Dis 2012;4:63–75.
Gudgin DF, Goyan RL, Pottier RH. New directions in photodynamic therapy. Cell Mol Biol 2002;48(8):939–54.
Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 2008;26(11):612-21.
Kato H. Photodynamic therapy for lung cancer-A review of 19 years' experience. J Photoch Photobio B 1998;42(2):96-9.
Lasers in cancer treatment. National cancer institute fact sheet. Available from: http: //www. cancer. gov/cancertopics/factsheet/Therapy/lasers. [Accessed July 07, 2014].
Lasers in cancer treatment. American cancer society. Available from: http: //www. cancer. org/treatment/treatments and side effects/treatment types/lasers-in-cancer treatment. [Accessed July 07, 2014].
Chen SL, Iddings DM, Scheri RP, Bilchik AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. Ca-Cancer J Clin 2006;56:292–309.
Veronesi U, Paganelli G, Luini A, Zurrida S, Galimberti V, Intra M, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983–90.
Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, et al. Safety of sentinel node biopsy in pregnant patients. with breast cancer. Ann Oncol 2004;15:1348–51.
Costello TJ, Donnelly WJ. Cryotherapy and join position sense in healthy participants: a systematic review. J Athl Training 2010;45(3):306-16.
Kerschan-Schindl K, Uher EM, Zauner-Dungl A, Fialka-Moser V, Martinez AD. Cold and cryotherapy. A review of the literature on general principles and practical application. Acta Med Austriaca 1998;25(3):73-8.
Lam JS, Belldegrun AS. Salvage cryosurgery of the prostate after radiation failure. Rev Urol 2004;6:S27–S36.
Finley DS, Belldegrun AS. Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications. Curr Urol Rep 2011;12(3):209–15.
Seifert JK, Junginger T. Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature. Technol Cancer Res Treat 2004;3(2):151-63.
Yiu WK, Basco MT, Aruny JE, Cheng SWK, Sumpio BE. Cryosurgery: a review. Int J Angiol 2007;16:1–6.
Blakely EA, Chang PY. Biology of charged parti¬cles. Cancer J 2009;15:271–84.
Kanai T, Furusawa Y, Fukutsu K, Itsukaichi H, Eguchi-Kasai K, Ohara H. et al. Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. Radiat Res 1997;147:78–85.
Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji H, Kato H. et al. Clinical results of carbon ion radiother¬apy at NIRS. J Radiat Res 2007;48:A1–A13.
Hada M, Georgakilas AG. Formation of clustered DNA damage after high-LET irradiation: a review. J Radiat Res 2008;49:203–10.
Tsuruoka C, Suzuki M, Hande MP, Furusawa Y, Anzai K, Okayasu R, et al. The difference in LET and ion species dependence for induction of initially measured and non-rejoined chromatin breaks in normal human fibroblasts. Radiat Res 2008;170:163–71.
Oishi T, Sasaki A, Hamada N, Ishiuchi S, Funayama T, Sakashita T, et al. Proliferation and cell death of human glio¬blastoma cells after carbon-ion beam exposure: morphologic and morphometric analyses. Neuropathol 2008;28:408–16.
Jinno-Oue A, Shimizu N, Hamada N, Wada S, Tanaka A, Shinagawa M, et al. Irradiation with carbon ion beams induces apoptosis, autophagy, and cellular senescence in a human glioma-derived cell line. Int J Radiat Onocol Biol Phys 2010;76:229–41.
Kawamura H, Tatei K, Nonaka T, Obinata H, Hattori T, Ogawa A, et al. Ceramide induces myogenic dif¬ferentiation and apoptosis in Drosophila Schneider cells. J Radiat Res 2009;50:161–9.
Hamada N, Hara T, Funayama T, Sakashita T, Kobayashi Y. Energetic heavy ions accelerate dif¬ferentiation in the descendants of irradiated normal human diploid fibroblasts. Mutat Res 2008;637:190–6.
Wang J, Wang JF, Li R, Guo C, Fournier C, Weyrather WK. The influence of fractionation on cell survival and premature differentiation after carbon ion irra¬diation. J Radiat Res 2008;49:391–8.
Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Kawaguichi A, et al. Particle irradiation suppresses meta¬static potential of cancer cells. Cancer Res 2005;65:113–20.
Mori E, Mori E, Takahashi A, Yamakawa N, Kirita T, Ohnishi T. High LET heavy ion radiation induces p53-independent apoptosis. J Radiat Res 2009;50:37–42.
Hamada N, Hara T, Omura-Minamisawa M, Funayama T, Sakashita T, Sora S, et al. Energetic heavy ions overcome tumor radioresistance caused by overexpression of Bcl-2. Radiother Oncol 2008;89:231–6.
Kitabayashi H, Shimada H, Yamada S, Yasuda S, Kamata T, Ando K, et al. Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation. Oncol Rep 2006;15:913–8.
Oohira G, Yamada S, Ochiai T, Matsubara H, Okazumi S, Ando K. Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with a p53 gene transfer. Int J Oncol 2004;25:563–9.
Imadome K, Iwakawa M, Nojiri K, Tamaki T, Sakai M, Nakawatari M. Upregulation of stress-response genes with cell cycle arrest induced by carbon ion irradiation in multiple murine tumor models. Cancer Biol Ther 2008;7:208–17.
Tamaki T, Iwakawa M, Ohno T, Imadome K, Nakawatari M, Sakai M, et al. Application of carbon-ion beams or γ-rays on primary tumors does not change the expression profiles of metastatic tumors in an in vivo murine model. Int J Radiat Oncol Biol Phys 2009;74:210–8.
Patil PM, Chaudhary PD, Sahu M, Duragkar NJ. Review article on gene therapy. Int J Gene 2012;4(1):74-9.
Yapeng H, Liwu F. Targeting cancer stem cells: a new therapy to cure cancer patients. Am J Cancer Res 2012;2(3):340-56.
Humadi AH, Zarros A, Liapi C, Saigh AR. Genetic basis and gene therapy trials for thyroid cancer. Cancer Genome Proteo 2010;7:31-50.
Alenzi F, Lotfy QM, Tamimi WG, Wyse RKH. Review: stem cells and gene therapy. Lab Hematol 2010;16:53-73.
Park J, Singha K, Son S, Kim J, Namgung R, Yun CO, et al. A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy. Cancer Gene Therapy 2012;19:741-8.
Raty JK, Pikkarainen JT, Wirth T, Yla-Herttuala S. Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol 2008;1:13–23.
Han DM, Huang ZG, Zhang W, Yu ZK, Wang Q, Ni X, et al. Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: Phase I clinical trial and follow up. Zhonghua YiXue ZaZhi 2003;83:2029–32.
Peng Z. Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther 2005;16:1016–27.
Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Sci 1996;274:373–6.
Hu JC, Coffin RS, Davis CJ, Graham NJ, Groves N, Guest PJ. et al. A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor. Clin Cancer Res 2006;12:6737–47.
Harrington KJ, Hingorani M, Tanay MA, Hickey J, Bhide SA, Clarke PM, et al. Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck. Clin Cancer Res 2010;16:4005–15.
Cross D, Burmester JK. Gene therapy for cancer treatment: past, present and future. Clin Med Res 2006;4:218-27.